Trials / Conditions / Central Nervous System Metastases

Central Nervous System Metastases

11 registered clinical trials studyying Central Nervous System Metastases.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS) NCT07447544	Institute of Oncology Ljubljana	N/A
Terminated	Focal Intraoperative Radiotherapy of Brain Metastases NCT03789149	AC Camargo Cancer Center	Phase 2
Terminated	Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC NCT03711422	National Cancer Centre, Singapore	Phase 1
Active Not Recruiting	Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC NCT03417544	Nancy Lin, MD	Phase 2
Completed	Whole Brain Radiation Using IMRT for Patients With Brain Metastases NCT02753790	New Mexico Cancer Research Alliance	N/A
Completed	Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer Wi NCT01783756	Jonsson Comprehensive Cancer Center	Phase 1 / Phase 2
Withdrawn	A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases NCT01939483	University of California, Irvine	N/A
Completed	Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases Fr NCT00992602	University of Washington	Phase 2
Completed	Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer NCT01706432	University of Chicago	—
Completed	Sunitinib in Treating Young Patients With Refractory Solid Tumors NCT00387920	National Cancer Institute (NCI)	Phase 1
Completed	Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases NCT00098605	National Cancer Institute (NCI)	Phase 2